Dhukka, the latest on my grapevine is that one or more of the major shareholders may be in trouble with the inventor but I am not sure if the company itself is directly involved.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025